Literature DB >> 22184396

Targeting the angiopoietin/Tie2 pathway: cutting tumor vessels with a double-edged sword?

Tina Cascone1, John V Heymach.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22184396     DOI: 10.1200/JCO.2011.38.7621

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  44 in total

1.  Understanding and targeting resistance to anti-angiogenic therapies.

Authors:  Jeffrey M Clarke; Herbert I Hurwitz
Journal:  J Gastrointest Oncol       Date:  2013-09

2.  Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding.

Authors:  Corey E Tabit; Phetcharat Chen; Gene H Kim; Savitri E Fedson; Gabriel Sayer; Mitchell J Coplan; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  Circulation       Date:  2016-06-28       Impact factor: 29.690

Review 3.  Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.

Authors:  Yujie Zhao; Alex A Adjei
Journal:  Oncologist       Date:  2015-05-22

Review 4.  Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis.

Authors:  V R Belum; C Serna-Tamayo; S Wu; M E Lacouture
Journal:  Clin Exp Dermatol       Date:  2015-05-25       Impact factor: 3.470

5.  Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers.

Authors:  Kriti Mittal; Henry Koon; Paul Elson; Pierre Triozzi; Afshin Dowlati; Helen Chen; Ernest C Borden; Brian I Rini
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

Review 6.  Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road.

Authors:  Jing-Si Wang; Qiu-Yun Zhang; Jin-Lian Cheng; Lan-Yu Chen; Nai-Li Yao; Gui-Zhi Sun; Yu-Ling Chu
Journal:  Chin J Integr Med       Date:  2018-06-25       Impact factor: 1.978

Review 7.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

8.  Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis.

Authors:  Viswanath Reddy Belum; Shenhong Wu; Mario E Lacouture
Journal:  Invest New Drugs       Date:  2013-05-23       Impact factor: 3.850

9.  Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.

Authors:  Thomas W Hoffmann; Hang-Phuong Pham; Chantal Bridonneau; Camille Aubry; Bruno Lamas; Camille Martin-Gallausiaux; Marco Moroldo; Dominique Rainteau; Nicolas Lapaque; Adrien Six; Mathias L Richard; Emilie Fargier; Marie-Emmanuelle Le Guern; Philippe Langella; Harry Sokol
Journal:  ISME J       Date:  2015-07-28       Impact factor: 10.302

10.  Magnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activities.

Authors:  Haruka Itakura; Achal S Achrol; Lex A Mitchell; Joshua J Loya; Tiffany Liu; Erick M Westbroek; Abdullah H Feroze; Scott Rodriguez; Sebastian Echegaray; Tej D Azad; Kristen W Yeom; Sandy Napel; Daniel L Rubin; Steven D Chang; Griffith R Harsh; Olivier Gevaert
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.